"Muscular Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Descriptor ID |
D009133
|
| MeSH Number(s) |
C10.597.613.612 C23.300.070.500 C23.888.592.608.612
|
| Concept/Terms |
Muscular Atrophy- Muscular Atrophy
- Atrophies, Muscular
- Atrophy, Muscular
- Muscular Atrophies
- Atrophy, Muscle
- Atrophies, Muscle
- Muscle Atrophies
- Muscle Atrophy
Neurogenic Muscular Atrophy- Neurogenic Muscular Atrophy
- Atrophies, Neurogenic Muscular
- Atrophy, Neurogenic Muscular
- Muscular Atrophies, Neurogenic
- Muscular Atrophy, Neurogenic
- Neurogenic Muscular Atrophies
- Neurotrophic Muscular Atrophy
- Atrophies, Neurotrophic Muscular
- Atrophy, Neurotrophic Muscular
- Muscular Atrophies, Neurotrophic
- Muscular Atrophy, Neurotrophic
- Neurotrophic Muscular Atrophies
|
Below are MeSH descriptors whose meaning is more general than "Muscular Atrophy".
Below are MeSH descriptors whose meaning is more specific than "Muscular Atrophy".
This graph shows the total number of publications written about "Muscular Atrophy" by people in this website by year, and whether "Muscular Atrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 4 | 5 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Muscular Atrophy" by people in Profiles.
-
Scavenging mitochondrial hydrogen peroxide by peroxiredoxin 3 overexpression attenuates contractile dysfunction and muscle atrophy in a murine model of accelerated sarcopenia. Aging Cell. 2022 03; 21(3):e13569.
-
Nox2 Inhibition Regulates Stress Response and Mitigates Skeletal Muscle Fiber Atrophy during Simulated Microgravity. Int J Mol Sci. 2021 Mar 23; 22(6).
-
Restoration of Sarcoplasmic Reticulum Ca2+ ATPase (SERCA) Activity Prevents Age-Related Muscle Atrophy and Weakness in Mice. Int J Mol Sci. 2020 Dec 22; 22(1).
-
Preclinical Models for Studying the Impact of Macrophages on Cancer Cachexia. Curr Protoc Pharmacol. 2020 12; 91(1):e80.
-
Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia. Sci Rep. 2020 08 18; 10(1):13968.
-
SIRT1-NOX4 signaling axis regulates cancer cachexia. J Exp Med. 2020 07 06; 217(7).
-
Molecular changes in transcription and metabolic pathways underlying muscle atrophy in the CuZnSOD null mouse model of sarcopenia. Geroscience. 2020 08; 42(4):1101-1118.
-
Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy. Redox Biol. 2019 09; 26:101308.
-
Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility. Sci Signal. 2019 08 13; 12(594).
-
Restoration of SERCA ATPase prevents oxidative stress-related muscle atrophy and weakness. Redox Biol. 2019 01; 20:68-74.